Melguizo Alonso, Consolación Author
5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
- Ortiz R.
- Prados J.
- Melguizo C.
- Arias J.
- Adolfina Ruiz M.
- Álvarez P.
- Caba O.
- Luque R.
- Segura A.
- Aránega A.
International Journal of Nanomedicine - 10/2/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.463 (2012)
- CiteScore: 9.2 (2020)
- SJR: 1.041 (2012
- SNIP: 1.543 (2012
- JCR 5-year Impact Factor: 4.027
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)
5-Fluorouracil-loaded poly(epsilon-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
- Ortiz, Raul
- Prados, Jose
- Melguizo, Consolacion
- Arias, Jose L.
- Ruiz, M. Adolfina
- Alvarez, Pablo J.
- Caba, Octavio
- Luque, Raquel
- Segura, Ana
- Aranega, Antonia
International Journal of Nanomedicine - 10/2/2012
- JCR Quartile: Q1 (2012)
- SJR Quartile: Q1
- JCR Impact Factor: 3.463 (2012)
- Category normalized Impact: 1.681 (2012)
- CiteScore: 7.1 (2019)
- SJR: 1.041 (2012
- SNIP: 1.544 (2012
- JCR 5-year Impact Factor: 4.027
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)
- ORCID
- Web of Science
How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment
- Prados J.
- Álvarez P.J.
- Melguizo C.
- Rodriguez-Serrano F.
- Carrillo E.
- Boulaiz H.
- Vélez C.
- Marchal J.A.
- Caba O.
- Ortiz R.
- Rama A.
- Aranega A.
Current Medicinal Chemistry - 1/4/2012
- JCR Quartile: Q4 (2012)
- SJR Quartile: Q1
- JCR Impact Factor: 4.07 (2012)
- Category normalized Impact: 0.169 (2012)
- CiteScore: 6.9 (2020)
- SJR: 1.538 (2012
- SNIP: 1.429 (2012
- JCR 5-year Impact Factor: 4.471
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Pharmacology (Q1); Molecular Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing (R) for efficient antitumor activity
- Martin-Banderas, Lucia
- Saez-Fernandez, Eva
- Angeles Holgado, Ma
- Matilde Duran-Lobato, Ma
- Prados, Jose C.
- Melguizo, Consolacion
- Arias, Jose L.
INTERNATIONAL JOURNAL OF PHARMACEUTICS - 25/02/2013
- SJR Quartile: Q1
- JCR Impact Factor: 3.785 (2013)
- CiteScore: 8.6 (2020)
- SJR: 1.377 (2013
- SNIP: 1.606 (2013
- JCR 5-year Impact Factor: 4.09
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
RNA interference in the treatment of colon cancer
- Prados, Jose
- Melguizo, Consolacion
- Roldan, Hector
- Alvarez, Pablo J.
- Ortiz, Raul
- Arias, Jose L.
- Aranega, Antonia
BioDrugs - 1/08/2013
- SJR Quartile: Q1
- JCR Impact Factor: 2.12 (2013)
- CiteScore: 9.4 (2020)
- SJR: 0.871 (2013
- SNIP: 0.928 (2013
- JCR 5-year Impact Factor: 2.79
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)
- Scopus
- ORCID
- Web of Science
Four accessory (supernumerary) intrathoracic ribs: A case report
- Prados, Jose
- Archilla, Francisco
- Melguizo, Consolacion
- Aranega, Antonia
Surgical and Radiologic Anatomy - 1/09/2013
- SJR Quartile: Q2
- JCR Impact Factor: 1.333 (2013)
- CiteScore: 1.9 (2020)
- SJR: 0.621 (2013
- SNIP: 1.222 (2013
- JCR 5-year Impact Factor: 1.212
- JCR Categories: SURGERY
- SJR Categories: Anatomy (Q2); Pathology and Forensic Medicine (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Surgery (Q2)
- Scopus
- ORCID
- Web of Science
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer
- Clares B.
- Biedma-Ortiz R.
- Sáez-Fernández E.
- Prados J.
- Melguizo C.
- Cabeza L.
- Ortiz R.
- Arias J.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS - 1/1/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.245 (2013)
- CiteScore: 9 (2020)
- SJR: 1.566 (2013
- SNIP: 1.721 (2013
- JCR 5-year Impact Factor: 4.737
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Antitumor properties of natural compounds and related molecules
- Robles-Fernández I.
- Rodríguez-Serrano F.
- Álvarez P.J.
- Ortiz R.
- Rama A.R.
- Prados J.
- Melguizo C.
- Álvarez-Manzaneda E.
- Aránega A.
Recent Patents on Anti-Cancer Drug Discovery - 26/11/2013
- SJR Quartile: Q1
- JCR Impact Factor: 2.863 (2013)
- CiteScore: 5.1 (2020)
- SJR: 1.162 (2013
- SNIP: 0.744 (2013
- JCR 5-year Impact Factor: 2.512
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)
- Scopus
- ORCID
- Web of Science
Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs
- Prados J.
- Melguizo C.
- Ortiz R.
- Perazzoli G.
- Cabeza L.
- Álvarez P.
- Rodriguez-Serrano F.
- Aranega A.
Anti-Cancer Agents in Medicinal Chemistry - 29/11/2013
- SJR Quartile: Q1
- JCR Impact Factor: 2.939 (2013)
- CiteScore: 3.5 (2020)
- SJR: 1.122 (2013
- SNIP: 0.836 (2013
- JCR 5-year Impact Factor: 3.37
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance
- Melguizo C.
- Prados J.
- Luque R.
- Ortiz R.
- Rama A.R.
- Caba O.
- Rodríguez-Serrano F.
- Álvarez P.J.
- Aránega A.
Cancer Chemotherapy and Pharmacology - 1/2/2013
- SJR Quartile: Q1
- JCR Impact Factor: 2.571 (2013)
- CiteScore: 5.5 (2020)
- SJR: 1.122 (2013
- SNIP: 0.974 (2013
- JCR 5-year Impact Factor: 2.56
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador